glp 1 users Just how many Americans are taking GLP-1s now GLP-1 weight loss drugs leave

Partnerships among pharmaceutical manufacturers, specialty pharmacies, and telehealth service providers are enhancing patient access and support services

At this time, retatrutide, one of the best-known triple hormone receptor agonists, is still investigational and has not been approved by any regulatory agency for routine patient use

Effects of TZD Use and Discontinuation on Fracture Rates in ACCORD Bone Study

And that's where she read about Contrave, a different type of oral weight-loss medication with solid science behind it

Update May 2026: PCOS Has a New Name As of May 12, 2026, polycystic ovary syndrome (PCOS) has been officially renamed polyendocrine metabolic ovarian syndrome (PMOS)

Glucagon-like peptide-1 receptor agonists (GLP-1RAs), such as Ozempic and Wegovy, have been widely prescribed for weight management